The Autonomous Pharmacy: Applying AI and ML to Medication Management Across the Care Continuum

Ken Perez
VP of Healthcare Policy
Omnicell, Inc.

Ken applies artificial intelligence (AI) and machine learning (ML) solutions to medication management. 

Every year, almost half a trillion dollars are spent on medications in the United States. This includes prescription drugs (and its supply chain), pharmacy benefit managers (PBMs), pharmacies, distributors, and providers dispensing and administering the medications. One out of every seven dollars we spend on healthcare is related to medications. 

Watch Ken Perez’s full presentation here

However, about 20-30 percent of prescriptions are not even filled. Many patients are not retrieving or using their pharmacy medications. The overall cost of medication non-adherence is $300 billion, according to the New England Healthcare Institute. 

A million emergency department (ED) visits a year occur from adverse drug effects in outpatient settings. Of those, about 1 out of 8 result in hospitalization.

How the healthcare industry is directly affected: 

Legislation has been passed to regulate and reform our healthcare system. As a result, we’ve created a burden  — a 3,000 percent growth in administrators. The growth of physicians has remained relatively flat, however. It costs the U.S. $15 billion a year on quality reporting. 

This weighs down not just on physicians and administrators, but also on pharmacists. 76 percent of pharmacists’ time is spent time on administrative, manual tasks, according to the American Society of Healthcare Pharmacists (ASHB) Full disclosure: Ken sits on the board. 

Proposed solution to disrupted, wasted healthcare: artificial intelligence and automation. 

The autonomous Pharmacy Advisory Board looks to transform the pharmacy care delivery model through the use of technology. This includes automation, data analytics, robotics, artificial intelligence and machine learning. 

The result: a fully autonomous pharmacy. 

How it’s done: by applying automation and robotics to the healthcare system. The ASHB is gaining intelligence so that pharmacy processes are performed more efficiently, safely, with better clinical outcomes. We can also better comply with regulations, and ultimately improve population health. 

Three use cases that can benefit from AI and ML:

Use case #1: drug shortages

We currently have over 100 drug shortages in the United States (a bipartisan bill addressing these shortages has currently been submitted to the Senate). 

Although the common definition of a shortage is when demand exceeds supply, the ASHP defines it as when a drug manufacturer can attest that there is an actual problem with supply and, as a result, is not able to meet the demand. 

Impact of drug shortages: 

  • Hard dollar and soft dollar costs. A hard dollar cost is buying more expensive substitutes. Brand names cost more than generics. Soft dollar costs include solutions research, and involve a good deal of coding, analysis and planning. 
  • Risk of patient safety. Medication errors can cause confusion and delays. 

Solutions using ML:

  • Proactive identification of risk, pre-shortage. Identify and apply risk scores on drugs that are based on multiple factors. 
  • Confronting the shortage when it actually occurs. Using algorithms to identify the therapeutic alternatives. This could all be automated;  caregivers can be notified. 

Use case #2: drug diversion 

This is a polite term for theft, when a drug is diverted away from its intended use and from the patients who need them. 

According to a Protenus 2019 Drug Diversion Report:

  • 47.2 million doses were diverted in 2018, up 126 percent vs. 2017
  • $454 million worth of drugs lost 
  • 94 percent of diversion incidents involved opioids. In fact, diversion is a major cause of the opioid crisis. 

Who is likely diverting

  • 15 percent of pharmacists
  • 10 percent of nurses
  • 8 percent of physicians

Use AI and ML for diversion monitoring and detection:

  • More comprehensive data matching makes it more difficult for diverters to avoid detection. 
  • Actionable insights to identify risk and a clear path to reconcile discrepancies. 
  • Minimize false positives. Not intended to create a Big Brother environment, but to draw an unbiased, non-judgemental conclusion that is based on data.  

Use case #3: Medication adherence 

  • Identify patients who are at high-risk of non-adherence (the ones most likely not to pick up or use their prescriptions). 
  • Identify patients who may cooperate with interventions. Provider organizations and retail pharmacies can optimize their interventions by using prescriptive, rank-ordered, preferred, and recommended intervention lists.

Longitudinal and large data sets can evaluate whether these algorithms and models are effective and successful. The goal is to measure the outcomes over time for large populations.

The bottom line: applying AI and ML may solve significant issues concerning medication management and use.

  • Overarching vision and ultimate goal: the autonomous pharmacy
  • Real work is currently being done
  • The ultimate test of value and the path to refinement: outcomes. We can actually test whether these outcomes are effective or not. 

Tags   •   Healthcare


Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts

Recent Posts

COVID-19 Curfew and Social Distancing Enforcement using AI enabled Drones - Amarjot Singh, PhDFounder & CEOSkyLark Labs LLC The SARS-CoV-2(also known as COVID-19 or Novel Corona Virus) infectious outbreak has rapidly…
“Ask Me Anything” with Roboticist & Program Lead of Racing Vehicles at General Motors - Harish SkumarRoboticist & Program Lead of Racing Vehicles General Motors Ai4 recently hosted an “Ask Me Anything” session with Harish…
Bottlenecks in Supply Chains & How AI Can Help - During this panel, industry experts (showed above) discussed the impact of COVID-19 on AI on Supply Chains. We’ve included a…
How COVID-19 is Impacting the State of AI in Supply Chains - During this panel, industry experts (showed above) discussed the impact of COVID-19 on AI on Supply Chains. We’ve included a…
How COVID-19 is Impacting the State of AI in Investment Management - On this panel, industry experts (listed above) discussed the impact of COVID-19 on AI on Investment Management. We've included a…
The State of AI in Investment Management - On this panel, industry experts (listed above) discussed the affects of AI on Investment Management. We've included a short transcription…
The State of AI in Banking - On this panel, industry experts (listed above) discussed what they are most excited about in AI in Banking. We've included…
How COVID-19 is Impacting the State of AI in Banking - On this panel, industry experts (listed above) discussed The State of AI in Banking and how COVID-19 is affecting it.…
The Ethics of AI: Who will be Responsible for the Decisions of AI Applications? - Ayodele Odubela Data Scientist SambaSafety One of the issues often debated in AI as it regards to ethics is who…
“Ask Me Anything” with Krzysztof Geras, PhD - Krzysztof Geras Assistant Professor NYU Department of Radiology Ai4's recently hosted an "Ask Me Anything" session with one of our…

Popular Posts

Does Healthcare AI Meet Basic Ethics Principles? - Ingrid Vasiliu-Feltes Chief Quality and Innovation Officer MEDNAX, Health Solutions Partner Over the past decade we have noticed an exponential…
AI/ML in Investment and Risk Management: Recent Applications, Use Cases, and Implementation Challenges - Arvind Rajan Managing Director - Head of Global & Macro PGIM Fixed Income Introduction Investing is a completely different ballgame…
Top AI Conferences - Interested in learning the latest in AI this year? We’ve compiled a list of the top artificial intelligence conferences in…
Artificial Intelligence & Cybersecurity: Math Not Magic - Wayne Chung CTO FBI Introduction The field of cybersecurity has slowly progressed from an art to a science. It has…
Machine Learning for Pricing and Inventory Optimization @ Macy’s - Jolene Mork Senior Data Scientist Macy's Iain Stitt Data Scientist Macy's Bhagyesh Phanse VP, Data Science Macy's Overview In this…
“Ask Me Anything” with Zappos’s Head of AI/ML Research & Platforms, Ameen Kazerouni - Ameen Kazerouni Head of AI/ML Research & Platforms Zappos Family of Companies Ai4 recently hosted an "Ask Me Anything" session…
Advancements at Siemens Healthineers in AI for Medical Imaging - Bimba Rao Head of Global Artificial Intelligence Engineering Siemens Healthineers Ultrasound Siemens Healthineers background  Siemens Healthineers builds healthcare products and…
Leveraging AI in Cybersecurity Risk Modeling & Mitigation - Christopher Novak Director, Threat Advisory Research Verizon Wireless Introduction Originally, there was a poor understanding of why cyber breaches were…
An Ensemble Approach to Predict Default Risk in Stress Testing - Yun Zheng VP of Innovation & Global Risk Analytics HSBC Overview This presentation discussed the importance of performing stress tests…
Machine Learning and Artificial Intelligence in Banking - Artit "Art" Wangperawong Distinguished Engineer US Bank Introduction Every company’s AI journey is different. We’re all trying to figure out…